Introduction {#s1}
============

Lignin, a heterogeneous aromatic polymer, accounts for up to 40% dry weight of terrestrial plant biomass (Ragauskas et al., [@B67]). It is primarily composed of *p*-hydroxyphenyl (H), guaiacyl (G), and sinapyl (S) subunits, polymerized by ether and C--C bonds (Boerjan et al., [@B13]). Lignin\'s heterogeneity and recalcitrant bonds create substantial barriers to its efficient microbial and chemical degradation. Industrial lignin depolymerization is gaining traction as a means to produce fuels and chemicals historically derived from petroleum (Ragauskas et al., [@B67]; Beckham et al., [@B11]). Yet, heterogeneous depolymerization products can require extensive separation and purification (Linger et al., [@B51]; Ragauskas et al., [@B67]). Bacterial biocatalysts provide a means of transforming mixtures of aromatic compounds to single compounds due to the convergent nature of their catabolic pathways, whereby substrates are transformed to central metabolites *via* shared intermediates, such as catechols (Linger et al., [@B51]; Eltis and Singh, [@B25]). Harnessing this biological funneling to refine lignin to high-value chemicals (Linger et al., [@B51]; Beckham et al., [@B11]; Eltis and Singh, [@B25]) is limited in part by a lack of knowledge of the catabolism of lignin-derived monomers.

Alkylphenols are a major class of aromatic compounds generated by a variety of lignin depolymerization technologies. For example, solvolysis of corn lignin produced 24 wt.% alkylated monolignins, 46% of which was 4-ethylphenol derived from H-subunits (Jiang et al., [@B39]). Alkylphenols were also major pyrolysis products of wheat straw black liquor lignin fractions (Guo et al., [@B30]). Existing depolymerization strategies can require multiple stages of pre-processing and depolymerization, high heat, or corrosive chemicals, and can produce dozens of alkylphenol and aromatic products (Ye et al., [@B83]; Kim et al., [@B42]; Asawaworarit et al., [@B7]). One promising depolymerization strategy that produces a narrow stream of alkylphenols is reductive catalytic fractionation (RCF) (Pepper and Lee, [@B62]). 4-Ethylphenol was a major RCF product of corn stover, comprising up to 16.4% of the resulting aromatic monomers (Anderson et al., [@B4]).

Two bacterial pathways for the aerobic catabolism of 4-ethylphenol have been reported, initially involving either oxidation of the alkyl side chain or hydroxylation of the aromatic ring. In *Pseudomonas putida* JD1, the alkyl side chain is oxidized by 4-ethylphenol methylhydroxylase to eventually yield hydroquinone (Darby et al., [@B22]; Hopper and Cottrell, [@B33]). In contrast, *Pseudomonas* sp. KL28 hydroxylates 4-ethylphenol to 4-ethylcatechol (Jeong et al., [@B38]). In these pathways, the hydroquinone and 4-ethylcatechol undergo *meta*-cleavage (Darby et al., [@B22]; Jeong et al., [@B38]). In KL28, the alkylphenol hydroxylase is a six-component enzyme encoded by genes organized in a single co-linear transcriptional unit within a *meta*-cleavage pathway gene cluster (Jeong et al., [@B38]). A homologous pathway degrades phenol in *Comamonas testosteroni* TA441 (Arai et al., [@B5]).

*Rhodococcus* is a genus of mycolic acid-producing Actinobacteria that catabolize a wide variety of aromatic compounds (Yam et al., [@B82]), including phenols (Kolomytseva et al., [@B44]; Gröning et al., [@B28]). These bacteria also have considerable potential as biocatalysts for the industrial production of compounds ranging from nitriles to steroids and high-value lipids (Alvarez et al., [@B2]; Round et al., [@B68]; Shields-Menard et al., [@B72]; Sengupta et al., [@B71]). In *Rhodococcus*, phenol catabolism is initiated by a two-component flavin-dependent monooxygenase (PheA1A2; Saa et al., [@B69]) to generate a catechol. PheA1A2 homologs in *Rhodococcus opacus* 1CP can also hydroxylate chlorophenols and 4-methylphenol (Gröning et al., [@B28]) to produce the corresponding catechols, which undergo *ortho-*cleavage (Maltseva et al., [@B55]; Kolomytseva et al., [@B44]) and subsequent transformation to central metabolites *via* the β-ketoadipate pathway. In *rhodococci*, the β-ketoadipate pathway is confluent, with branches responsible for protocatechuate and catechol catabolism converging at PcaL, a β-ketoadipate enol-lactonase (Patrauchan et al., [@B60]; Yam et al., [@B82]). However, some *rhodococci* appear to have pathways responsible for the catabolism of alkylated aromatic compounds *via meta*-cleavage (Jang et al., [@B37]). Elucidating 4-alkylphenol metabolism in *rhodococci* will improve our understanding of Actinobacterial aromatic degradation and support the development of *Rhodococcus* strains as platforms for industrial lignin upgrading.

Genomic islands (GIs) are DNA segments likely to have been acquired by horizontal gene transfer. They are characterized by altered nucleotide characteristics (e.g., GC content), syntenic conservation, and frequent presence of mobility genes \[transposases, insertion sequences (IS), and integrases\] (Hacker and Kaper, [@B32]; Juhas et al., [@B41]). They can be further identified by the absence of genomic regions in closely related strains (Hacker et al., [@B31]). GIs can confer resistance, virulence, symbiosis, and catabolic pathways (Dobrindt et al., [@B23]; Juhas et al., [@B41]). For example, the self-transferable *clc* element enabling 3- and 4-chlorocatechol and 2-aminophenol catabolism was identified as a GI in several *Gamma*- and *Betaproteobacteria* strains (Gaillard et al., [@B26]). Recent horizontal gene transfer may have played less of a role in shaping the *Rhodococcus jostii* RHA1 genome than in other bacteria such as *Burkholderia xenovorans* LB400, which has a similarly sized genome (McLeod et al., [@B57]). Further, although RHA1 contains a high number of aromatic pathways, genes encoding these pathways are slightly underrepresented in the identified GIs. GIs can ameliorate in host genomes through nucleotide optimization or loss of mobility elements (Lawrence and Ochman, [@B48]; Juhas et al., [@B41]), reducing our effectiveness at predicting ancestral genomic additions. However, examination of GIs in multiple related genomes with an ensemble of predictive software can improve our understanding of the role of GIs in the evolution of bacterial catabolic pathways.

This study sought to identify catabolic pathways required for 4-alkylphenol catabolism. We report on the genomic, transcriptomic, and enzymatic characterization of 4-alkylphenol catabolism in a newly isolated 4-ethylphenol-degrading bacterium, *Rhodococcus rhodochrous* EP4 ([Figure 1A](#F1){ref-type="fig"}), as well as RHA1. The activity of a novel two-component alkylphenol monooxygenase (AphAB) was characterized. Gene deletion analysis was employed to identify the subsequent route of catechol catabolism. Genomic analysis identified a putative *aph* GI, providing new evolutionary insight into the *aph meta-*cleavage pathway in *Rhodococcus*. Knowledge gained by this study will facilitate the efficient valorization of lignin following its depolymerization.

![Isolation and growth of 4-ethylphenol-catabolizing strain *R. rhodochrous* EP4. **(A)** Schematic of EP4 isolation from compost on 4-ethylphenol, which is produced from reductive lignin depolymerization. **(B)** Circular genome map for EP4. Outer genomic track: coding sequences by strand; inner track: insertion sequences; lines: GC content (%). MC, *meta*-cleavage pathway gene cluster; OC, *ortho*-cleavage pathway gene cluster. **(C)** Growth of EP4 on 1 mM 4-ethylphenol or 2 mM succinate controls as optical density at 600 nm (OD~600~). Points and error bars reflect mean and standard error (*n* = 3). **(D)** Colony-forming units (CFU) during growth in **(B)**. Points and horizontal bar indicate individual measurements and mean. **(E)** Removal of 4-ethylphenol and succinate in EP4 cultures. **(F)** Growth of RHA1 on 1 mM 4-ethylphenol or 2 mM succinate. **(G)** CFU during growth in **(F)**. **(H)** Removal of 4-ethylphenol and succinate in RHA1 cultures.](fmicb-10-01862-g0001){#F1}

Materials and Methods {#s2}
=====================

Bacterial Strains and Growth Conditions
---------------------------------------

Liquid enrichment cultures were inoculated with either \~4-month-aged agricultural compost (\~25 cm depth) from The University of British Columbia farm (49° 14\' 57.8904" N, 123° 14\' 0.0492" W) or forest soil from Pacific Spirit Park in Vancouver, Canada. The cultures contained 1.0 mM 4-ethylphenol (≥97.0% Sigma-Aldrich, St. Louis, U.S.A.) as sole organic substrate in M9-Goodies (Bauchop and Elsden, [@B10]; Elder, [@B24]). The cultures were incubated at 30°C with shaking at 200 rpm for 2 weeks. Removal of 4-ethylphenol was monitored by GC-MS, after which cultures were transferred to fresh medium, 0.5% inocula. After three serial transfers, isolates were obtained by plating on homologous medium solidified with 1.5% purified agar. Colonies appeared in 10 days. Individual colonies were transferred to liquid media and replated on solid media for colony isolation. *R. rhodochrous* strain DSM43241 was purchased from DSMZ (Braunschweig, Germany).

EP4 and RHA1 cultures for RNA extraction were grown overnight at 30°C on LB broth (200 rpm), diluted to 0.05 OD~600~, and washed thrice in M9 with no supplement, and grown to mid-log phase on 50 ml M9-Goodies with 1.0 mM 4-ethylphenol or succinate. EP4 was additionally grown on 1.0 mM benzoate (99%, Sigma-Aldrich). Additional screening of EP4, *R*. *rhodochrous* DSM43241, RHA1, and mutant strains used 5 ml of M9-Goodies with 1.0 mM phenol (≥99%, VWR International, Ltd., Mississauga, Canada), 3-methylphenol (*m-*cresol; 99% Sigma-Aldrich), 4-methylphenol (99% Sigma-Aldrich), 4-propylphenol (\> 99%, TCI), 3,4-dimethylphenol (DMP) (99% Sigma-Aldrich), 2,4-DMP (98% Sigma-Aldrich), 4-hydroxyphenylacetate (HPA) (98% Sigma-Aldrich), 4-hydroxybenzioic acid (HBA) (99%, Sigma-Aldrich), or 0.5 mM 4-nitrophenol (NP) (≥99%, Sigma-Aldrich), incubated for 24 h. Cells were lysed by boiling in 1 M NaOH and protein quantified using the Micro BCA™ Protein Assay (Thermo Fisher Scientific Inc., Waltham, U.S.A.) and a VersaMax™ microplate reader (Molecular Devices LLC, San Jose, U.S.A.).

DNA Manipulation, Plasmid Construction, and Gene Deletion
---------------------------------------------------------

DNA was isolated, manipulated, and analyzed using standard protocols (Sambrock and Russel, [@B70]). *E. coli* and RHA1 were transformed with DNA by electroporation using a MicroPulser with GenePulser cuvettes (Bio-Rad). To produce N-terminal His~6~-tagged AphA~EP4~, AphB~EP4~, and AphC~RHA1~ (see [Table 1](#T1){ref-type="table"}), C6369_RS01585, C6369_RS01550, and RHA1_RS18750 were amplified from genomic DNA using Phusion Polymerase™ with the oligonucleotides listed in [Supplementary Table 1](#SM1){ref-type="supplementary-material"}. The nucleotide sequence of the cloned genes was verified. The Δ*aphA* and Δ*aphC* mutants were constructed using a *sacB* counter selection system (van der Geize et al., [@B80]). Five hundred-base pair flanking regions of RHA1_RS18785 and RHA1_RS18750 were amplified from RHA1 genomic DNA using the primers listed in [Supplementary Table 1](#SM1){ref-type="supplementary-material"}. The resulting amplicons were inserted into pK18mobsacB linearized with EcoRI using Gibson Assembly. The nucleotide sequences of the resulting constructs were verified. Kanamycin-sensitive/sucrose-resistant colonies were screened using PCR, and the gene deletion was confirmed by sequencing.

###### 

Genes in the alkylphenol *meta*-cleavage pathway.

  **Gene**   **EP4[^a^](#TN1){ref-type="table-fn"}**   **RHA1[^b^](#TN2){ref-type="table-fn"}**   **Product[^c^](#TN3){ref-type="table-fn"}**               **Best Hit[^d^](#TN4){ref-type="table-fn"}**                                      **% ID[^e^](#TN5){ref-type="table-fn"}**   **References**
  ---------- ----------------------------------------- ------------------------------------------ --------------------------------------------------------- --------------------------------------------------------------------------------- ------------------------------------------ --------------------------------
  *aphA*     RS01585                                   RS18785 (89%)                              Alkylphenol hydroxylase, oxygenase                        4-Nitrophenol 2-monooxygenase, oxygenase (NphA1) Q8RQQ0                           87                                         Takeo et al., [@B78]
  *aphB*     RS01580                                   RS18780 (85%)                              Alkylphenol hydroxylase, reductase                        NADH-dependent flavin reductase (NphB1) Q8RQP9                                    81                                         Takeo et al., [@B78]
  *aphC*     RS01550                                   RS18750 (87%)                              Alkylcatechol 2,3-dioxygenase                             Biphenyl-2,3-diol 1,2-dioxygenase (BphC)[^f^](#TN6){ref-type="table-fn"} Q0S9X1   87                                         PDB entry, unpublished
  *aphD*     RS01565                                   RS18765 (89%)                              5-Alkyl-2-hydroxy-muconate-6-semialdehyde dehydrogenase   4-Hydroxymuconic-semialdehyde dehydrogenase (DmpC) P19059                         45                                         Nordlund and Shingler, [@B59]
  *aphE*     RS01575, RS01600                          RS18775, RS18820 (69%)                     5-Alkyl-2-hydroxymuconate tautomerase                     2-Hydroxymuconate tautomerase (DmpI) P49172                                       38                                         Shingler et al., [@B73]
  *aphF*     RS01605                                   RS18825 (85%)                              Enol 5-alkyl-2-oxalocrotonate decarboxylase               4-Oxalocrotonate decarboxylase (NahK, DmpH) Q1XGK3                                85                                         Tsuda and Iino, [@B79]
  *aphG*     RS01610                                   RS18830 (85%)                              2-Keto-4-alkylpentenoate hydratase                        2-Keto-4-pentenoate hydratase (MhpD) P77608                                       42                                         Pollard and Bugg, [@B63]
  *aphH*     RS01560                                   RS18760 (93%)                              4-Hydroxy-2-alkylketopentenoate aldolase                  4-Hydroxy-2-oxovalerate aldolase (DmpG, MhpE) P51016                              48                                         Shingler et al., [@B73]
  *aphI*     RS01555                                   RS18755 (91%)                              Alkylacetaldehyde dehydrogenase                           Acetaldehyde dehydrogenase (HsaG, MphF) P9WQH3                                    57                                         Carere et al., [@B19]
  *aphR*     RS01590                                   RS18790 (55%)                              Aph transcriptional regulator                             AraC family transcriptional regulator Q88H39                                      39                                         Nelson et al., [@B58]
  *aphQ*     RS01595                                   RS18810 (64%)                              Aph transcriptional regulator                             AraC family transcriptional regulator Q88H39                                      36                                         Nelson et al., [@B58]
  *aphS*     RS01615                                   RS18835 (70%)                              Aph transcriptional regulator                             IclR family transcriptional regulator Q0SH23                                      31                                         Pouyssegur and Stoeber, [@B64]

*Locus in EP4 (C6369_RSXXXXX)*.

*Locus in RHA1 (RHA1_RSXXXXX). Percent identity with EP4 homolog in parentheses*.

*Where "alkyl" represents the variable-length 4-alkyl side chain*.

*Gene name and Uniprot identifier of closest characterized homolog*.

*Percent identity of best hit and EP4 homolog determined by Clustal Omega alignment*.

*Also annotated as catechol 2,3-dioxygenase (DmpB)*.

Enzyme Production and Purification
----------------------------------

The production and purification of AphA~EP4~, AphB~EP4~, and AphC~RHA1~ are described in [Supplementary Methods](#SM2){ref-type="supplementary-material"}.

GC/MS Analysis
--------------

Growth substrate depletion was analyzed in culture supernatants using an Agilent Technologies (Santa Clara, U.S.A.) 6890N gas chromatograph equipped with a 30-m Agilent 190915-433 capillary column and a 5973 mass-selective detector (GC/MS). Briefly, 400-μl samples of culture supernatant were amended with 3-chlorobenzoic acid (as internal standard), extracted with ethyl acetate (1:1 v/v), and dried under a nitrogen stream. The extract was suspended in pyridine and derivatized with trimethylsilyl for 1 h at 60°C. One-microliter injections were analyzed using the following parameters: transfer line temperature of 325°C, run temperature of 90°C for 3 min, and then ramped to 290°C at 12°C min^−1^ with a 10-min final hold. Peaks from raw trace files were aligned and integrated using *xcms* in R 3.4.4 (R Core Team, [@B66]) against 4-ethylphenol and succinate standards. Values were normalized to the area of the internal standard and expressed as a percent of maximum peak area.

Nucleic Acid Extraction and Sequencing
--------------------------------------

RNA was extracted from cellular pellets from 15 ml of EP4 and RHA1 cultures using TRIzol™ (Thermo-Fisher) and Turbo™ DNase (Thermo-Fisher). Quality and quantity of nucleic acids were assessed using 1% \[w/v\] agarose gel electrophoresis and Qubit fluorometric quantitation (Thermo-Fisher), prior to storage at −80°C. Approximately 1 μg of RNA underwent Ribo-Zero rRNA removal (Illumina, San Diego, U.S.A.), TruSeq LT (Illumina) library preparation, and sequencing using HiSeq4000 2 × 100 bp. Genomic DNA was extracted using CTAB. Fifteen micrograms was pulse-field electrophoresis size-selected and sequenced with one Pacific Biosciences (PacBio) RS II SMRT cell.

Bioinformatics
--------------

A *de novo* draft genome was assembled with HGAP in the SMRT Analysis v2.3 pipeline (Chin et al., [@B21]) and MeDuSa 1.6 scaffolding (Bosi et al., [@B15]). Circularizing the genome sequence was attempted using Circlator 1.5.5 (Hunt et al., [@B36]), and plasmid detection was attempted using PlasmidFinder 2.0.1 (Carattoli et al., [@B18]). Annotation used the NCBI Prokaryotic Genome Annotation Pipeline (PGAP) 4.4 and BLASTp against the Protein Data Bank (e-value 10^−3^). Quality control, filtering, and trimming of RNA reads used Trimmomatic 0.3.6 defaults (Bolger et al., [@B14]). Assembly used Trinity 2.4.0 (Grabherr et al., [@B27]). Transcript quantification used HTSeq 0.9.1 (Anders et al., [@B3]), FeatureCounts 1.5.0-p3 (Liao et al., [@B50]), and Salmon 0.8.1 (Patro et al., [@B61]). Differential expression was analyzed using *DeSeq2* 1.18.1 (Love et al., [@B53]) with false discovery rate (*fdr*) correction. RT-qPCR conditions are in [Supplementary Methods](#SM2){ref-type="supplementary-material"}. All data visualization used *ggplot2* 3.1.0 unless otherwise noted.

Phylogenomic Characterization
-----------------------------

Protein sequences were structurally aligned with T-Coffee 11.00 Expresso (Armougom et al., [@B6]); maximum-likelihood trees were generated using the best of 100 RAxML 8.0.0 iterations using the PROTGAMMALG model (Stamatakis, [@B74]) and visualized with iTOL v4 (Letunic and Bork, [@B49]). GI regions were predicted with IslandViewer 4 (Hsiao et al., [@B34]; Bertelli et al., [@B12]). All available *Rhodococcus* genomes (*n* = 325) were downloaded from NCBI RefSeq. Genomic alignment with a subset of genomes ([Supplementary Table 2](#SM1){ref-type="supplementary-material"}) used *nucmer* 3.1 (Marçais et al., [@B56]) and visualized with *circlize* 0.4.5 (Gu et al., [@B29]). Ribosomal protein trees were constructed as in Hug et al. ([@B35]).

Enzyme Assays
-------------

AphAB~EP4~ activity was measured spectrophotometrically by following the *meta*-cleavage of the produced 4-ethylcatechol in a coupled assay with AphC~RHA1~ at 25 ± 0.5°C. The standard assay was performed in 200 μl of air-saturated 20 mM MOPS and 90 mM NaCl (*I* = 0.1 mM, pH 7.2) containing 0.5 mM 4-ethylphenol, 5 μM AphA~EP4~, 1 μM AphB~EP4~, 0.2 μMAphC~RHA1~, 1,000 U ml^−1^ of catalase, 1 mM NADH, and 2.5 μM FAD. Components were incubated for 30 s, and then the reaction was initiated by adding NADH and was monitored at 400 nm. Absorbance was monitored using a Varian Cary 5000 spectrophotometer controlled by WinUV software. One unit of activity, *U*, was defined as the amount of enzyme required to hydroxylate of 1 nmol substrate per minute. Extinction coefficients for methyl-, ethyl-, and propylcatechol cleavage at 400 nm were 18,600, 15,100, and 19,400 M^−1^ cm^−1^, respectively, calculated by differences in liberation of O~2~ from alkylcatechol cleavage by 0.2 nmol AphC~RHA1~ monitored using a Clark-type polarographic O~2~ electrode OXYG1 (Hansatech, Pentney, UK) connected to a circulating water bath. Details of additional enzyme end point assays are provided in the [Supplementary Methods](#SM2){ref-type="supplementary-material"}.

Results {#s3}
=======

Isolation and Genomic Characterization of a 4-Ethylphenol-Degrading *Rhodococcus* Strain
----------------------------------------------------------------------------------------

In order to isolate environmental strains capable of degrading alkylphenols, enrichment cultures with 4-ethylphenol as a sole organic growth substrate were inoculated with either forest soil or compost and incubated at 30°C. Those cultures inoculated with compost demonstrated superior potential for 4-ethylphenol degradation and were used for subsequent isolation of strain EP4. The 16S rRNA gene (27F-1492R; Lane, [@B46]) of EP4 shared 100% sequence identity with that of *R. rhodochrous* NBRC 16069. *De novo* assembly produced a 5.72-Mb, high-quality, single-scaffold EP4 genome sequence ([Figure 1B](#F1){ref-type="fig"}) containing 5,198 predicted genes: 4,942 protein coding sequences, 12 rRNAs, 54 tRNAs, three other RNAs, and 187 pseudogenes. Only a single origin of replication (*oriC*) was found, at 1,863,144 bp, and no plasmids were detected ([Supplementary Table 2](#SM1){ref-type="supplementary-material"}). The lack of PacBio long reads overlapping the 5′ and 3′ genome regions indicated that the EP4 genome is linear.

EP4 grew on 1.0 mM 4-ethylphenol to stationary phase within 14 h in shake flasks ([Figure 1C](#F1){ref-type="fig"}). Growth on 4-ethylphenol was verified by plating CFUs ([Figure 1D](#F1){ref-type="fig"}). GC-MS analysis indicated that 4-ethylphenol was completely removed from the medium during growth ([Figure 1E](#F1){ref-type="fig"}), with no metabolites detected.

Quasi-Mapping-Based Quantification of Prokaryotic Gene Expression
-----------------------------------------------------------------

We used transcriptomics to identify 4-ethylphenol catabolic genes in EP4 without *a priori* bias. Transcriptome reads were aligned strand-wise to predict transcriptional start sites in the EP4 genome ([Figure 2A](#F2){ref-type="fig"}). Read alignment is a common but time-consuming step in prokaryotic RNA-Seq pipelines ([Supplementary Figure 1A](#SM1){ref-type="supplementary-material"}). We therefore compared quasi-mapping to genomic coding regions using Salmon (Patro et al., [@B61]) with alignment-based read counting software. Salmon results were numerically ([Supplementary Figure 1B](#SM1){ref-type="supplementary-material"}) and statistically equivalent (*p*~*adj*~ = 0.21) ([Supplementary Figure 1C](#SM1){ref-type="supplementary-material"}) to FeatureCounts, with strong correlation to RT-qPCR expression ($R_{\text{adj}}^{2}$ = 0.91, *p* \< 0.001) ([Supplementary Figure 1D](#SM1){ref-type="supplementary-material"}). Salmon was about eight times faster than FeatureCounts and superior to htseq in terms of total counts and accuracy and was therefore used for gene quantification prior to differential expression analysis using *DESeq2*.

![Transcriptomic and genomic identification of the 4-ethylphenol catabolic pathway genes in *R. rhodochrous* EP4. **(A)** RNA reads from cells grown on 4-ethylphenol or succinate mapped to the EP4 gene clusters encoding catechol *meta*-cleavage and *ortho*-cleavage. **(B)** *Deseq2* differential-expression analysis showing log2 fold-change (FC) on 4-ethylphenol vs. succinate (FDR-corrected *p* values: \**p*~fdr~ \< 0.001). Points show values for *n* = 3 replicates; horizontal bar indicates mean. P450, cytochrome P450 gene; Red., P450 reductase. **(C)** Proposed funneling of 4-ethylphenol into the alkylcatechol *meta*-cleavage pathway (upper) and not the phenol *ortho*-cleavage pathway (lower). TCA, tricarboxylic acid cycle.](fmicb-10-01862-g0002){#F2}

Transcriptomic Analysis of 4-Ethylphenol Metabolism *via meta-*Cleavage
-----------------------------------------------------------------------

Growth on 4-ethylphenol vs. succinate significantly modulated expression of 559 genes with *p*~*fdr*~ \< 0.001. Nine of the 16 most upregulated genes occurred in a cluster encoding a proposed alkylphenol catabolic pathway, *aphABCDEFGHIQRS* ([Table 1](#T1){ref-type="table"}). This cluster includes *aphAB*, encoding a two-component alkylphenol hydroxylase discussed below, and *aphC*, encoding an extradiol dioxygenase that we subsequently identified as alkylcatechol 2,3-dioxygenase. The *aphA* gene displayed the highest upregulation on 4-ethylphenol. The gene cluster is organized as four putative operons based on transcriptomic data and operon prediction with BPROM: *aphAB, aphHIDE, aphE2FGS*, and *aphG2H2I2* ([Figure 2A](#F2){ref-type="fig"}). The deduced Aph pathway catabolizes 4-ethylphenol to pyruvate and butyryl-CoA ([Figure 2C](#F2){ref-type="fig"}), similar to the Dmp pathway of *Pseudomonas* sp. strain CF600 that catabolizes dimethylphenols (Shingler et al., [@B73]) and phenol (Powlowski and Shingler, [@B65]). Based on the transcriptomic data, the resultant butyryl-CoA is degraded to central metabolites by an aerobic fatty acid degradation pathway (Jimenez-Diaz et al., [@B40]) encoded by butyryl-CoA dehydrogenase genes (locus tags: C6369_RS06395, C6369_RS20140, C6369_RS07820, C6369_RS05465), enoylCoA hydratase (C6369 \_RS19405, C6369_RS19860), 3-hydroxybutyryl-CoA dehydrogenase (C6369_RS03325, C6369_RS06400), and acetyl-CoA acyltransferase (C6369_RS17095, C6369_RS15900, C6369_RS19850) ([Supplementary Figure 2](#SM1){ref-type="supplementary-material"}).

The *catABC* cluster encoding catechol 1,2-dioxygenase and other enzymes feeding into the β-ketoadipate pathway was also significantly upregulated during growth on 4-ethylphenol, although much less highly than the *aph* genes. No *ortho*-cleavage metabolites were detected in the culture supernatants ([Figure 1D](#F1){ref-type="fig"}), and the genes encoding the downstream β-ketoadipate pathway, *pcaBLIJ*, were not upregulated ([Figure 2B](#F2){ref-type="fig"}). Overall, the data suggest that 4-ethyphenol is catabolized *via meta-*cleavage.

Characterization of a Two-Component Akylphenol Hydroxylase, AphAB
-----------------------------------------------------------------

We hypothesized that the highly upregulated *aphA* gene (L~2~FC = 11.5) encodes the oxygenase component of a novel alkylphenol monooxygenase, based on its location within the *aph* cluster as well as the phylogenetic and functional data presented below. The *aphB* gene, encoding a flavin reductase was co-transcribed with *aphA* ([Figures 2A,B](#F2){ref-type="fig"}). The upregulation of *aphA* and *aphC* genes in EP4 during growth on 4-ethylphenol was confirmed using RT-qPCR ([Supplementary Figure 3](#SM1){ref-type="supplementary-material"}).

To establish the physiological role of AphAB from EP4, the oxygenase, and reductase components were each overproduced in *E. coli* and purified to apparent homogeneity. The reconstituted AphAB~EP4~ hydroxylated 4-ethylphenol to 4-ethylcatechol ([Figure 3A](#F3){ref-type="fig"}). The enzyme also catalyzed the hydroxylation of 4-methylphenol, 4-propylphenol ([Figure 3B](#F3){ref-type="fig"}), and, to a much lesser extent, 4-NP ([Figure 3C](#F3){ref-type="fig"}). However, AphAB~EP4~ did not detectably transform phenol ([Figure 3B](#F3){ref-type="fig"}) or 4-HPA ([Figure 3C](#F3){ref-type="fig"}). In an assay measuring cytochrome *c* reduction, AphB~EP4~ preferentially utilized NADH and flavin adenine dinucleotide (FAD) ([Figure 3D](#F3){ref-type="fig"}), as reported for PheB homologs (Straube, [@B75]; Saa et al., [@B69]; Gröning et al., [@B28]).

![Characterization of AphAB~EP4~. **(A)** Hydroxylation of 4-ethylphenol to 4-ethlycatechol by purified AphAB~EP4~. Reaction mixtures contained 20 μM of each enzyme component and 100 μM substrate, and were incubated overnight. **(B)** Specific activity of AphAB~EP4~ for select phenols. Activity was measured using a coupled, spectrophotometric assay. **(C)** Transformation of 4-HPA and 4-NP by AphAB~EP4~. Conditions as in **(A)**. **(D)** Cofactor and substrate preference of AphB~EP4~. Reductase activity was measured using cytochrome *c*. **(E)** Phylogenetic tree constructed using structural-based alignment and RAxML. HPA, hydroxyphenylacetate; NP, nitrophenol; FAD, flavin adenine dinucleotide; FMN, flavin mononucleotide; RF, riboflavin.](fmicb-10-01862-g0003){#F3}

Annotation of Additional Genes
------------------------------

During growth of EP4 on 4-ethylphenol, genes encoding phenol hydroxylase oxygenase and reductase, *pheA* and *pheB*, respectively, adjacent to the *cat* gene cluster, were additionally upregulated in a single putative regulon ([Figure 2B](#F2){ref-type="fig"} and [Supplementary Figure 3](#SM1){ref-type="supplementary-material"}). In structure-based alignments, PheA~EP4~ and AphA~EP4~ clustered with separate 4-NP hydroxylases, rather than the clade of characterized phenol hydroxylases ([Figure 3E](#F3){ref-type="fig"}). More specifically, PheA~EP4~ and AphA~EP4~ clustered most closely, respectively, with NphA1 from *Rhodococcus* sp. BUBNP1 (WP_059382681.1; Sengupta et al., [@B71]) and NphA1 from *Rhodococcus* sp. PN1 (Q8RQQ0; Takeo et al., [@B78]). Despite 100% sequence identity with NphA1~BUBNP1~, PheA~EP4~ was annotated based on sequence similarity to known phenol hydroxylases ([Figure 3E](#F3){ref-type="fig"}). In support of this annotation, EP4 lacks a 4-NP catabolism gene cluster and was unable to grow on 4-NP, while it did grow on phenol (discussed below). PheA ~EP4~ shares 82% identity with PheA1(1) (ABS30825.1) in *Rhodococcus erythropolis* UPV-1 (Saa et al., [@B69]) and 65% identity with a chlorophenol 4-monooxygenase (Q8GMG6) from *Streptomyces globisporus* (Liu et al., [@B52]; [Supplementary Table 3](#SM1){ref-type="supplementary-material"}; [Supplementary Figure 4](#SM1){ref-type="supplementary-material"}). These similarities suggest that PheA~EP4~ may have broad substrate specificity.

In EP4, genes encoding AraC-family transcriptional regulators (TRs) were found directly adjacent to and in the opposite orientation as *aphAB* and *pheAB* ([Figure 2A](#F2){ref-type="fig"} and [Supplementary Figure 5](#SM1){ref-type="supplementary-material"}). These AraC-family TRs were annotated as AphR and PheR, respectively. Another AraC-family TR is encoded by a gene immediately downstream of *aphR*, which has a distinct phylogeny from AphR ([Supplementary Figure 5](#SM1){ref-type="supplementary-material"}) and was annotated as AphQ. Finally, an IclR-family TR is encoded by the last gene of the *aphE2FGS* operon.

Syntenic Conservation of EP4 *aph* Gene Cluster in Rhodococci
-------------------------------------------------------------

The above comparative analyses of hydroxylase proteins revealed homologs of the EP4 *aphA* gene in several other rhodococci. In RHA1, a putative *aphA* gene ([Table 1](#T1){ref-type="table"}) was previously annotated as an aromatic ring hydroxylase possibly involved in steroid degradation (McLeod et al., [@B57]) and there were three previously identified *pheA* homologs ([Supplementary Table 3](#SM1){ref-type="supplementary-material"}; Gröning et al., [@B28]). Local alignment of the 13 Aph proteins against proteins predicted from all 325 *Rhodococcus* genomes identified 75 strains with full or partial (≥7 genes) putative Aph pathways, including RHA1 ([Supplementary Figure 6A](#SM1){ref-type="supplementary-material"}). Related pathways were also found in other Actinobacteria, but this study focused on the rhodococcal pathway. RHA1 *aph* genes displayed syntenic conservation with the EP4 *aph* cluster ([Figure 4](#F4){ref-type="fig"}), except for an additional butyryl-CoA dehydrogenase gene (RHA1_RS18815). The *aphCHIDE* region was conserved in all *aph*-containing genomes based on *nucmer* alignment ([Figure 4](#F4){ref-type="fig"} and [Supplementary Figure 6B](#SM1){ref-type="supplementary-material"}). The EP4 and RHA1 Aph proteins shared 55% to 93% identity (median = 86%) ([Table 1](#T1){ref-type="table"}).

![Identification of a putative *aph* genomic island in rhodococci. Alignment of *Rhodococcus* genomes to EP4 reference with *nucmer* ordered by RAxML tree calculated from concatenated alignment of 16 ribosomal protein sequences, predicted RHA1 genomic islands, GC content (%), and syntentic organization of *aph* gene clusters showing genomic islands predicted using IslandViewer4. *Nucmer* alignment regions shown with dashed line. *aphA*, 4-alkylphenol 3-monooxygenase, oxygenase gene; *aphB*, 4-alkylphenol 3-monooxygenase, reductase gene; *aphC*, alkylcatechol 2,3-dioxygenase gene; *bph*, biphenyl catabolism gene cluster; P450, cytochrome P450 gene; Red., P450 reductase. The single origin of replication (*oriC*) shown with orange diamond. Detail of the *aph* region alignments in [Supplementary Figure 6B](#SM1){ref-type="supplementary-material"}.](fmicb-10-01862-g0004){#F4}

Identification of *aph* genes in RHA1 motivated us to test its growth on alklyphenols. Consistent with the occurrence of the putative Aph pathway in RHA1, this strain grew on 4-ethylphenol ([Figures 1F-- H](#F1){ref-type="fig"}, [5A](#F5){ref-type="fig"}), with concomitant upregulation of the *aph* genes ([Figure 5B](#F5){ref-type="fig"}). Specifically, *aphA* and *aphC* were highly upregulated (L~2~FC, 14.3 and 10.0, respectively). In contrast to EP4, when RHA1 grew on 4-ethylphenol, it did not upregulate any of its three *pheA* genes or any of the ring-cleavage dioxygenase genes associated with the *pheA* genes, including *catA* (RHA1_RS11595), *catA2* (RHA1_RS35920), and a plasmid-borne catechol 2,3-dioxygenase gene (RHA1_RS35970; McLeod et al., [@B57]; [Figure 5B](#F5){ref-type="fig"}).

![Molecular genetic analysis of 4-ethylphenol catabolism in RHA1. **(A)** Growth of WT, Δ*aphA*, and Δ*aphC1* RHA1 strains on 1 mM 4-ethylphenol or 2 mM succinate. **(B)** Expression of select genes in WT and Δ*aphA* RHA1 strains during growth on 1 mM 4-ethylphenol or 2 mM succinate using RT-qPCR. Colors indicate cleavage pathway. Points and horizontal bars show individual measurements (*n* = 3) and mean. Significance levels following Bonferroni-corrected two-tailed Student\'s *t*-tests (\**p*~bon~ \< 0.05; \*\**p*~bon~ \< 0.01; \*\*\**p*~bon~ \< 0.001). **(C)** Protein yield of WT, Δ*aphC*, and Δ*pcaL* RHA1 strains as well as EP4 and *R*. *rhodochrous* DSM43241 on phenolic substrates. Protein measured after 24 h incubation. DMP, dimethylphenol; EP, ethylphenol; HBA, hydroxybenzoic acid; HPA; hydroxyphenylacetate; MP, methylphenol; NP, nitrophenol; PP, propylphenol.](fmicb-10-01862-g0005){#F5}

Gene Deletion Analysis of 4-Alkylphenol Ring Cleavage
-----------------------------------------------------

Efforts to genetically transform EP4 were unsuccessful. However, the above analysis demonstrated the presence of the Aph pathway in RHA1, a strain with existing gene deletion mutants and well-studied systems for genetic manipulation. Because RHA1 is genetically tractable and contains an orthologous Aph pathway, we constructed Δ*aphA* and Δ*aphC* deletion mutants and used these together with an existing Δ*pcaL* mutant to further investigate 4-ethylphenol catabolism. The Δ*aphC* mutant did not grow on either 1.0 mM 4-ethylphenol or 4-propylphenol ([Figures 5A,C](#F5){ref-type="fig"}) demonstrating that both compounds are exclusively metabolized by *meta-*cleavage. No metabolites, including 4-ethylcatechol, accumulated in the culture supernatant, possibly due to lack of excretion of any transformed products (data not shown).

However, Δ*aphA* did grow on 4-ethylphenol ([Figure 5A](#F5){ref-type="fig"}). It appears that one or more of three PheA homologs from RHA1 may catalyze 4-ethylphenol hydroxylation and compensate for the deletion of *aphA*. While the corresponding *pheA* genes were not upregulated in wild-type RHA1 growing on 4-ethylphenol vs. succinate, they were upregulated 7.6 to 8.8 L~2~FC in the Δ*aphA* mutant ([Figure 5B](#F5){ref-type="fig"}), while the plasmid-borne *C23D* gene was not upregulated. Finally, the Δ*pcaL* mutant grew on alkylphenols but did not grow on either phenol or 4-HBA, indicating that the latter two substrates are catabolized solely *via ortho-*cleavage pathways ([Figure 5C](#F5){ref-type="fig"}).

Identification of a Putative *aph* GI
-------------------------------------

The *aph* gene cluster (\~17 kb) occurs within 117 and 4.2 kb regions predicted to be two of 61 GIs (or 38 non-overlapping GI regions) identified in EP4 using IslandViewer4 ([Figure 4](#F4){ref-type="fig"} and [Supplementary Table 2](#SM1){ref-type="supplementary-material"}). These GI elements do not include *aphAB* or *aphE* in EP4, but do in three other *Rhodococcus* strains. These putative GIs are located near the 3′ end of the EP4 chromosome assembly in a 600-kb region of apparent genomic instability, as it contains high IS density ([Figure 1A](#F1){ref-type="fig"}) and 36 predicted GIs ([Figure 4](#F4){ref-type="fig"}). The GI-like characteristics of these elements containing the *aph* cluster include a −5.8% deviation from the mean GC content, presence of mobility genes (integrases, transposases, ISs), and absence of the region in closely related genomes following alignment (Langille et al., [@B47]; [Figure 4](#F4){ref-type="fig"} and [Supplementary Figure 6](#SM1){ref-type="supplementary-material"}). They are not located near a tRNA sequence, indicating that it is not likely a mobile integrative and conjugative element (ICE) (Burrus and Waldor, [@B16]). More generally, 7.4% of the EP4 genome and 9.2% of the RHA1 genome were predicted to occur on GIs ([Supplementary Table 2](#SM1){ref-type="supplementary-material"}).

Analysis of 37 complete, full-length *Rhodococcus* genomes found that 16 carried genes encoding a complete Aph pathway. The *aph* genes are predicted to be fully or partially contained in a GI in six of these strains and to occur immediately downstream of a GI in a seventh, RHA1. This genomic region was conserved in three *Rhodococcus* clades: one containing EP4 and *R. pyridinivorans* strains; one containing *R. jostii, R. opacus*, and *Rhodococcus wratislaviensis* strains; and one containing *Rhodococcus* sp. Eu32 ([Supplementary Figure 6](#SM1){ref-type="supplementary-material"}). With the exception of a partial *aph* cluster in *R. rhodochrous* ATCC 21198, the *aph* genes were not found in any of the 13 other *R. rhodochrous* genomes including strain DSM43241. Accordingly, DSM43241 could not grow on 4-ethylphenol and 4-propylphenol, but grew on phenol, 4-HBA, 3-methylphenol, and 4-methylphenol ([Figure 5C](#F5){ref-type="fig"}).

Discussion {#s4}
==========

In this study, we used a variety of approaches to identify an Aph pathway responsible for the catabolism of alkylphenols *via meta*-cleavage in *Rhodococcus*. Catabolism is initiated by AphAB, a two-component hydroxylase that transforms the alkylphenol to the corresponding alkylcatechol ([Figures 2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). To date, only six-component proteobacterial alkylphenol hydroxylases have been reported (Arai et al., [@B5]; Jeong et al., [@B38]). The ensuing Aph pathway generates pyruvate and an acyl-CoA following *meta*-cleavage of 4-alkylcatechol. The length of the acyl-CoA produced depends on the alkyl side chain of the growth substrate. This is in contrast to the Phe and Nph pathways that catabolize phenol and 4-NP, respectively, *via ortho-*cleavage (Takeo et al., [@B77]; Szoköl et al., [@B76]; Sengupta et al., [@B71]).

The activity of AphAB~EP4~ is consistent with its phylogenetic relationship with two-component phenolic hydroxylases. Thus, the clade containing AphA~EP4~ and AphA~RHA1~ includes an NphA1 but no characterized PheA or HpaB ([Figure 3](#F3){ref-type="fig"}). In keeping with this classification, AphAB~EP4~ had weak activity with 4-NP ([Figure 3C](#F3){ref-type="fig"}) but did not detectably transform phenol or 4-HPA. However, the determinants of substrate specificity of these enzymes are not clear. The catalytic residues of these hydroxylases (Kim et al., [@B43]; Chang et al., [@B20]) are conserved in AphA: Arg119, Tyr123, and His161 (AphA~EP4~ numbering; [Supplementary Figure 4](#SM1){ref-type="supplementary-material"}). In a structurally characterized HpaB:4-HPA binary complex, the substrate\'s carboxylate is coordinated by Ser197 and Thr198 (Kim et al., [@B43]). In PheA, NphA, and AphA, these residues are His214 and Tyr215, suggesting that they do not contribute to the enzyme\'s substrate specificity despite their predicted interaction with the *para*-substituent of the substrate.

The Aph pathway is similar to the Dmp pathway described in *Pseudomonas* sp. strain CF600 (Shingler et al., [@B73]). However, it is clear that the Aph pathway has a distinct substrate specificity because neither EP4 nor RHA1 grew on 2,4- or 3,4-DMP ([Figure 5C](#F5){ref-type="fig"}) and *aph* pathway mutants of RHA1 grew on phenol. We had previously suggested that some of the *aph* genes could be involved in steroid degradation (McLeod et al., [@B57]) due to their similarity to known steroid catabolic genes (van der Geize et al., [@B80]). Further, in a recently published structure of AphC~RHA1~, the enzyme was identified as 2,3-dihydroxybiphenyl dioxygenase ([Table 1](#T1){ref-type="table"}). However, AphC is encoded in a gene cluster upregulated on 4-alkylphenols and is essential for growth of RHA1 on those compounds, supporting annotation of this rhodococcal Aph *meta-*cleavage pathway, with AphC as an alkylcatechol 2,3-dioxygenase.

4-Ethylphenol strongly induced *aphAB* expression. This is likely due to positive induction of the AphR TR, just as phenol activates *pheA2A1* expression by PheR in RHA1 (Szoköl et al., [@B76]), and 4-NP activates *npaA2A1* expression by NphR in *Rhodococcus* sp. PN1 (Takeo et al., [@B77]). AphR was identified based on conservation or syntentic organization relative to PheRAB, as both TR elements are expressed in opposition to their respective oxygenase components. AphR, PheR, and NphR are all AraC-family TRs. AphR and PheR may play a role in the unexpected ability of the RHA1 Δ*aphA* mutant to grow on 4-ethylphenol. The lack of *pheA1-3* expression in wild-type RHA1 ([Figure 5B](#F5){ref-type="fig"}) strikingly contrasts with the upregulation of these genes in the Δ*aphA* mutant ([Figure 5C](#F5){ref-type="fig"}). This phenomenon requires further study, as aphR and pheR bear little phylogenetic similarity ([Supplementary Figure 5A](#SM1){ref-type="supplementary-material"}). Indeed, the putative *aphA* promotor sequences (−10: CAGGAG; −35: CCGTCT) ([Supplementary Figure 5B](#SM1){ref-type="supplementary-material"}) bear more similarity to the T80 promotor of *Mycobacterium tuberculosis* (Bashyam et al., [@B9]) than with the rhodococcal *pheA* promotors. Related to this, homologs of PheAB in *R. opacus* 1CP hydroxylated 4-methylphenol with about twice the specific activity as with phenol (Gröning et al., [@B28]), further suggesting that the RHA1 PheABs may hydroxylate 4-ethylphenol.

In addition to 4-ethylphenol, alkylguaiacols and alkylsyringols commonly occur in lignin depolymerization streams (Ye et al., [@B83]; Jiang et al., [@B39]; Kim et al., [@B42]; Anderson et al., [@B4]; Guo et al., [@B30]; Asawaworarit et al., [@B7]). Interestingly, genes encoding a cytochrome P450 and reductase are linked to the *aph* clusters in some rhodococci ([Figures 2, 4](#F2){ref-type="fig"}). Further, these were the second and third most highly upregulated genes in EP4 during growth on 4-ethylphenol versus succinate (both L~2~FC = 11.1; [Figure 2B](#F2){ref-type="fig"}). The P450 shares 65% sequence identity with a guaiacol *O*-demethylase (Mallinson et al., [@B54]), suggesting that the rhodococcal enzyme has a similar role, and that these strains may also funnel methoxylated compounds into the Aph pathway.

The ability of RHA1 and EP4 to catabolize 4-ethylphenol and other alkylphenols is of potential use in upgrading lignin streams generated by RCF and other depolymerization strategies. The Aph *meta*-cleavage pathway harbored by these strains contrasts with the *ortho*-cleavage pathways targeted to date in the design of biocatalysts for lignin valorization (Abdelaziz et al., [@B1]; Beckham et al., [@B11]; Barton et al., [@B8]). This is largely due to the identified economic potential of some of the *ortho*-cleavage metabolites. For example, *cis, cis*-muconate resulting from *ortho*-cleavage can be used to make adipic acid and terephthalic acid (Xie et al., [@B81]; Beckham et al., [@B11]; Barton et al., [@B8]). However, alkylphenols may be funneled through *ortho-*cleavage by oxidizing the *para*-side chain to 4-hydroxyacetophenone or hydroquinone (Darby et al., [@B22]). Alternatively, oleaginous *Rhodococcus* strains such as RHA1 may be modified to use the Aph pathway to produce lipid-based commodity chemicals (e.g., Round et al., [@B68]) offering a method for valorization of alkylphenols *via* fatty-acid synthesis in this genus.

We found genes encoding the Aph pathway in several *Rhodococcus* strains, including oleaginous strains such as RHA1 and *R. opacus* B4 ([Figures 3A](#F3){ref-type="fig"}, **4**). However, the absence of an *aph* cluster in most *R*. *rhodochrous* strains (e.g., DSM43241) demonstrates that phylogenetically related strains can have important metabolic differences. Previous studies suggested that recent horizontal gene transfer did not play a large role in generating RHA1\'s considerable catabolic capabilities (McLeod et al., [@B57]). In several rhodococci, putative GIs did not contain all of the *aph* genes. This could represent the imprecision of the prediction tools, incomplete amelioration of the element, or reflect that these GIs arose from separate insertion events. Patchwork *aph* GIs are consistent with the theorized modular origins of GIs (Juhas et al., [@B41]). Fermentation of plant-derived aromatic compounds, including cinnamic acids, by yeasts and lactic acid bacteria can naturally produce alkylphenols (Caboni et al., [@B17]; Kridelbaugh et al., [@B45]). The apparent complete loss of the *aph* genes in other *R. rhodochrous* strains may result without selective alkylphenol exposure if it otherwise has a deleterious effect on overall fitness. Testing these regions for their excision capacity was beyond the scope of this work, but remains an intriguing prospect. We posit that the presence of aromatic compounds in compost selected for microorganisms capable of 4-ethylphenol catabolism, including EP4.

In this study, we described a newly isolated, 4-ethylphenol-catabolizing strain, EP4, a novel alkylphenol hydroxylase, AphAB, and its role in funneling alkylphenols into the Aph *meta-*cleavage pathway in some *Rhodococcus* strains. We showed that this pathway is associated with putative GIs, primarily found in strains from contaminated soil environments. Characterizing 4-ethylphenol metabolism in EP4 and RHA1 advances our capacity for bio-refinement of reductively depolymerized lignin subunits from sustainable chemical feedstocks.

Data Availability {#s5}
=================

The EP4 genome assembly can be downloaded from NCBI (<https://www.ncbi.nlm.nih.gov/assembly/GCA_003004765.2>). The transcriptome data can be downloaded from SRA at accessions SRR6877528--SRR6877536. All data can be downloaded and the full transcriptomic analysis can be run using a custom pipeline found at: <https://github.com/levybooth/Rhodococcus_Transcriptomics>.
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